Le Lézard
Classified in: Health, Science and technology
Subject: FVT

Mylan Announces Voluntary Delisting from the Tel Aviv Stock Exchange (TASE)



HERTFORDSHIRE, England and PITTSBURGH, Nov. 10, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it is voluntarily delisting the company's ordinary shares from trading on the Tel Aviv Stock Exchange (TASE). Under Israeli law, the delisting of Mylan's ordinary shares from the TASE will become effective in three months, on Feb. 12, 2018.

When Mylan first listed its shares on the TASE in November 2015, in connection with its attempt to acquire Perrigo, it committed to maintaining the listing for at least one year. Mylan has been listed on the TASE for more than two years.

Mylan's Chairman of the Board Robert J. Coury noted: "Over the last two years, we have learned that many of our Israeli institutional shareholders actually hold their shares in Mylan on the NASDAQ. Further, Mylan's holding on the TASE represents less than 3.5% of our total shareholdings and the average trading volume on the TASE is less than 3.5% of our global trading volume. Given these factors and the fact that the TASE's trading hours and days are different from other markets, our board of directors decided at this time that it would not be in Mylan's best interests to continue our listing on the TASE. That said, we do appreciate the ties we have forged with the Israeli institutional market."

Coury continued, "More importantly, over the last two years, I have had the privilege of becoming acquainted with the dynamic Israeli business environment and the strong work ethic of its people. As a result, we remain committed to considering future investments and other business development opportunities in Israel."

Mylan's shares will continue to be listed on the NASDAQ, and all of its ordinary shares now traded on the TASE may be transferred to the NASDAQ.

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com. We routinely post information that may be important to investors on our website at investor.mylan.com.

Mylan (PRNewsfoto/Mylan N.V.)

SOURCE Mylan N.V.


These press releases may also interest you

at 07:00
MONTREAL, Nov. 17, 2017 /CNW Telbec/ - Once again this year, the Karnak Shriners and the Shriners Hospital for Children® - Canada will participate in the frenzy of the Santa Claus Parade this Saturday, November 18th. The Karnak Shriners are part of...

at 07:00
Broadcast/Interview/photo opportunities: TORONTO, Nov. 18, 2017 /CNW/ - WHAT   "It's Always Something" presented by Richardson GMP, Canada's #1 Variety Show, to be held Saturday, November 18th at Toronto's Sony Centre in support of Gilda's...

at 05:30
MONTREAL, Nov. 16, 2017 /CNW Telbec/ - On Saturday, November 18, 2017, the Corporation d'urgences-santé will mobilize about 100 of its volunteer employees, including several paramedics, to give children from four major Montreal hospitals (CHU...

at 01:00
DOHA, Qatar, November 18, 2017 /PRNewswire/ -- More than 700 international healthcare experts, key opinion leaders, primary care specialist, surgeons, physician and health practitioners attended the opening ceremony of the 3rd International Primary...

17 nov 2017
HOUSTON, Nov. 17, 2017 /PRNewswire/ -- Medistar Corporation ("Medistar") announced today that it has begun development of a major medical tower, located at 6700 Main Street, the home of the Best Western hotel, which will soon be demolished. The site...

17 nov 2017
Nishnawbe Aski Nation and the governments of Ontario and Canada solidify work plan to achieve health system transformation for 49 First Nations communities in Northern Ontario TIMMINS, ON, Nov. 17, 2017 /CNW/ - Nishnawbe Aski Nation (NAN), the...




News published on 10 november 2017 at 16:45 and distributed by: